Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
MedCap AB, established in 2001 and headquartered in Stockholm, Sweden, is a private equity firm specializing in the acquisition and development of small to medium-sized companies within the life sciences sector. The firm focuses on three primary business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap's portfolio includes subsidiaries such as Abilia, which operates in assistive technology; Cardiolex, specializing in ECG solutions; and Unimedic, involved in specialty pharmaceuticals. The company primarily targets investments in Northern Europe, aiming to support businesses with international growth potential. MedCap typically acquires majority stakes, providing capital, expertise, and networks to foster long-term development.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
MedCap ABJohnson & Johnson
Last price
kr 552.50$273.20
Currency
SEK
USD
kr 8.3B$658B
30.1841.49
kr 18.30$6.58
0.470.21
0$5.28
01.96%
Sector
HealthHealth
Employees
663138,200
Ticker
Skr MCAP$JNJ
Primary listing
XSTONYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in SkrMCAP or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.